Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02157155Completed
Randomised, open-label trial (2 arms), sponsored by Aarhus University. Primary endpoint: Insulin signaling expressed as a CHANGE in phosphorylation of intracellular target proteins and CHANGE in mRNA expression of target genes in muscle- and fat-tissue. Started Jun 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02157155.